We serve Chemical Name:MNITMT,4-Methyl-3-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-4H-1,2,4-triazole CAS:177653-76-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![MNITMT,4-Methyl-3-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-4H-1,2,4-triazole](https://a.dearchem.com/CAS2/177653-76-8.png)
Chemical Name:MNITMT,4-Methyl-3-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-4H-1,2,4-triazole
CAS.NO:177653-76-8
Synonyms:Methoxyresorufin;MNITMT
Molecular Formula:C7H8N6O2S
Molecular Weight:240.24200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:553.7ºC at 760mmHg
Density:1.68g/cm3
Index of Refraction:1.784
PSA:119.65000
Exact Mass:240.04300
LogP:1.13120
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Methoxyresorufin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MNITMT physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MNITMT Use and application,Methoxyresorufin technical grade,usp/ep/jp grade.
Related News: The QbD studies were designed concisely to minimize the use of the API and evaluate the critical product parameters that could affect the product quality attributes of the drug product, per FDA’s QbD guidance. ethyl 2-(2-ethoxy-2-oxoethyl)quinoline-3-carboxylate manufacturers The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. 6-Hydroxy-5-Methoxy-1-Indanone suppliers CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 5-bromo-2-methoxy-3-nitrobenzonitrile vendor & factory.
